Literature DB >> 31042697

Single-cell transcriptomic analysis of Alzheimer's disease.

Hansruedi Mathys1,2, Jose Davila-Velderrain3,4, Zhuyu Peng1,2, Fan Gao1,2, Shahin Mohammadi3,4, Jennie Z Young1,2, Madhvi Menon4,5,6, Liang He3,4, Fatema Abdurrob1,2, Xueqiao Jiang1,2, Anthony J Martorell1,2, Richard M Ransohoff7, Brian P Hafler4,5,6,8, David A Bennett9, Manolis Kellis10,11, Li-Huei Tsai12,13,14.   

Abstract

Alzheimer's disease is a pervasive neurodegenerative disorder, the molecular complexity of which remains poorly understood. Here, we analysed 80,660 single-nucleus transcriptomes from the prefrontal cortex of 48 individuals with varying degrees of Alzheimer's disease pathology. Across six major brain cell types, we identified transcriptionally distinct subpopulations, including those associated with pathology and characterized by regulators of myelination, inflammation, and neuron survival. The strongest disease-associated changes appeared early in pathological progression and were highly cell-type specific, whereas genes upregulated at late stages were common across cell types and primarily involved in the global stress response. Notably, we found that female cells were overrepresented in disease-associated subpopulations, and that transcriptional responses were substantially different between sexes in several cell types, including oligodendrocytes. Overall, myelination-related processes were recurrently perturbed in multiple cell types, suggesting that myelination has a key role in Alzheimer's disease pathophysiology. Our single-cell transcriptomic resource provides a blueprint for interrogating the molecular and cellular basis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31042697      PMCID: PMC6865822          DOI: 10.1038/s41586-019-1195-2

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  53 in total

Review 1.  The Cellular Phase of Alzheimer's Disease.

Authors:  Bart De Strooper; Eric Karran
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

Review 2.  Neural mechanisms of ageing and cognitive decline.

Authors:  Nicholas A Bishop; Tao Lu; Bruce A Yankner
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

Review 3.  Untangling Genetic Risk for Alzheimer's Disease.

Authors:  Anna A Pimenova; Towfique Raj; Alison M Goate
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

4.  Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease.

Authors:  Raffaella Nativio; Greg Donahue; Amit Berson; Yemin Lan; Alexandre Amlie-Wolf; Ferit Tuzer; Jon B Toledo; Sager J Gosai; Brian D Gregory; Claudio Torres; John Q Trojanowski; Li-San Wang; F Brad Johnson; Nancy M Bonini; Shelley L Berger
Journal:  Nat Neurosci       Date:  2018-03-05       Impact factor: 24.884

Review 5.  The road to restoring neural circuits for the treatment of Alzheimer's disease.

Authors:  Rebecca G Canter; Jay Penney; Li-Huei Tsai
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 6.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 8.  Alzheimer's disease.

Authors:  Colin L Masters; Randall Bateman; Kaj Blennow; Christopher C Rowe; Reisa A Sperling; Jeffrey L Cummings
Journal:  Nat Rev Dis Primers       Date:  2015-10-15       Impact factor: 52.329

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 10.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

View more
  492 in total

1.  Nuclear receptor binding factor 2 (NRBF2) is required for learning and memory.

Authors:  Xiaosen Ouyang; Israr Ahmad; Michelle S Johnson; Matthew Redmann; Jason Craver; Willayat Y Wani; Gloria A Benavides; Balu Chacko; Peng Li; Martin Young; Anil G Jegga; Victor Darley-Usmar; Jianhua Zhang
Journal:  Lab Invest       Date:  2020-04-29       Impact factor: 5.662

2.  In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.

Authors:  Ramsey Najm; Kelly A Zalocusky; Misha Zilberter; Seo Yeon Yoon; Yanxia Hao; Nicole Koutsodendris; Maxine Nelson; Antara Rao; Alice Taubes; Emily A Jones; Yadong Huang
Journal:  Cell Rep       Date:  2020-07-28       Impact factor: 9.423

Review 3.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

4.  Genome-wide In Vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity.

Authors:  Mary H Wertz; Mollie R Mitchem; S Sebastian Pineda; Lea J Hachigian; Hyeseung Lee; Vanessa Lau; Alex Powers; Ruth Kulicke; Gurrein K Madan; Medina Colic; Martine Therrien; Amanda Vernon; Victoria F Beja-Glasser; Mudra Hegde; Fan Gao; Manolis Kellis; Traver Hart; John G Doench; Myriam Heiman
Journal:  Neuron       Date:  2020-01-30       Impact factor: 17.173

5.  Sex: a key consideration in understanding the etiology of psychiatric disorders and improving treatment

Authors:  Cara Tannenbaum; Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2019-11-01       Impact factor: 6.186

Review 6.  Prioritization of cell types responsive to biological perturbations in single-cell data with Augur.

Authors:  Jordan W Squair; Michael A Skinnider; Matthieu Gautier; Leonard J Foster; Grégoire Courtine
Journal:  Nat Protoc       Date:  2021-06-25       Impact factor: 13.491

7.  Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks.

Authors:  Hans-Ulrich Klein; Martin Schäfer; David A Bennett; Holger Schwender; Philip L De Jager
Journal:  PLoS Comput Biol       Date:  2020-04-07       Impact factor: 4.475

Review 8.  When function follows form: Nuclear compartment structure and the epigenetic landscape of the aging neuron.

Authors:  Johannes C M Schlachetzki; Tomohisa Toda; Jerome Mertens
Journal:  Exp Gerontol       Date:  2020-02-14       Impact factor: 4.032

9.  Dissecting heterogeneous cell populations across drug and disease conditions with PopAlign.

Authors:  Sisi Chen; Paul Rivaud; Jong H Park; Tiffany Tsou; Emeric Charles; John R Haliburton; Flavia Pichiorri; Matt Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-30       Impact factor: 11.205

10.  Dysregulation of brain and choroid plexus cell types in severe COVID-19.

Authors:  Andrew C Yang; Fabian Kern; Patricia M Losada; Maayan R Agam; Christina A Maat; Georges P Schmartz; Tobias Fehlmann; Julian A Stein; Nicholas Schaum; Davis P Lee; Kruti Calcuttawala; Ryan T Vest; Daniela Berdnik; Nannan Lu; Oliver Hahn; David Gate; M Windy McNerney; Divya Channappa; Inma Cobos; Nicole Ludwig; Walter J Schulz-Schaeffer; Andreas Keller; Tony Wyss-Coray
Journal:  Nature       Date:  2021-06-21       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.